http://www.reportsnreports.com/TriMark Publications, LLC Market Research Reports XML feedhttp://www.reportsnreports.com/reports/75216-molecular-diagnostics-in-cancer-testing.htmlMolecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. This TriMark Publications report describes the specif...Sat, 06 Apr 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/232672-coagulation-diagnostic-testing-markets.htmlCoagulation testing, which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the in vitro diagnostics market for the foreseeable future. Many of the new models of laboratory coagulation testing devices and reagents, which are dominated by prothrombin time (PT) and activated partial thromboplastin time (aPTT), will include upgrades such as greater automation and the integration of more esoteric coagulation tests such as D-dimer and antiphospholipid assays. This TriMark Publications report provides a comprehensive examination of the coagulation and antiplatelet testing market. It examines the available and emerging technologies bei...Sat, 06 Apr 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/75231-regenerative-medicine-markets.htmlRegenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new advancements in the ability to repair or replace damaged human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not), or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remediate countless physical maladies that have perpetually afflicted humans and oth...Fri, 01 Mar 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/231060-hemoglobin-a1c-testing-markets.htmlHemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. This TriMark Publications report describes the specific market segment that encompasses hemoglobin A1c testing for diagnosing and monitoring diabetes. The study reviews all of the generally accepted clinical analytical methods that are cur...Fri, 01 Mar 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/231061-therapeutic-drug-monitoring-markets.htmlTherapeutic drug monitoring (TDM) is an important clinical assessment of drug plasma concentrations that also yields information regarding the efficacy, toxicity levels and potential drug-drug interactions of agents with a narrow therapeutic index. Ultimately, therapeutic drug monitoring testing provides clinical information to optimize dosage regimes and prevent adverse reactions and lack of treatment compliance. This TriMark Publications report analyzes the therapeutic drug monitoring market and the various market segments within it, e.g., antiepileptics, antiarrhythmics, antibiotics, antineoplastics, bronchodilators, immunosuppressives and HIV/AIDS drugs. The report also examines drug analysis ...Fri, 01 Mar 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/231062-pain-management-treatment-markets.htmlPain management describes a particular set of drugs, analgesics, which are specifically used as therapeutics to control pain in the clinic. As pain affects 1.5 billion people worldwide, these drugs are one of the major segments of the central nervous system (CNS) therapies market. This TriMark Publications analysis focuses on the role of pain management drugs in clinical use and in drug development for acute pain, chronic pain, neuropathic path and nociceptive pain. The report discusses drug development and targeted therapeutics, as well as their use in clinical trials. New approaches meant to aid in development of drugs for therapeutic use are emphasized. The study also analyzes almost all of the...Fri, 01 Mar 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/231063-new-oral-anticoagulants-markets.htmlAnticoagulants decrease the ability of the blood to create harmful blood clots that can ultimately leading to a heart attack or stroke. Although sometimes referred to as blood thinners, they do not actually thin the blood and only help prevent the formation of new blood clots. For more than 50 years and until recently, the only oral anticoagulants were vitamin K antagonists such as warfarin. Pradaxa (dabigatran), Xarelto (rivaroxaban), Eliquis (apixaban) and other new oral anticoagulants have several advantages over warfarin, including no periodical laboratory monitoring and more predictable effects with fixed doses. This TriMark Publications report provides a thorough overview of these and other ...Fri, 01 Mar 2013 00:00:00 GMThttp://www.reportsnreports.com/reports/75190-clinical-chemistry-analyzers.htmlClinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily-collected bodily fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The analysis of virtually any biologically-active substance--any place in the body--can loosely be defined as clinical chemistry. In fact, traditional specialization barriers such as microbiology, hematology, blood banking, immunology and even anatomical pathology are rapidly fading, both operationally and ...Sat, 01 Dec 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75197-diabetes-metabolic-syndrome-and-cardiovascular-disease.htmlThere has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among adults across the world. To compound the global diabetes epidemic, health professionals are witnessing an alarming increase in inflammatory diseases resulting from adult onset (i.e., Type 2) diabetes. This phenomenon is referred to as metabolic syndrome where a con...Sat, 01 Dec 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75211-mammography-world-markets.htmlBreast cancer is the most common type of cancer in women, affecting one in eight during their lives. Mammography is the most valuable method for detecting potentially cancerous anomalies in the breast. As such, the mammography equipment segment is poised for a major new phase of growth fueled by the availability of new technologies. Mammograms are images of the breast tissue produced from low radiation X-rays. The three types of mammography systems are: 1) analog systems, 2) computed tomography (CR) systems and 3) full-field digital mammography (FFDM). The analog systems are the conventional types, and they use X-ray films for capturing the breast images. The CR systems are also film-based, but ar...Sat, 01 Dec 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75217-molecular-diagnostics-in-infectious-disease-testing.htmlThis report describes the specific segment of the in vitro diagnostics market known as molecular diagnostics testing for infectious disease. In the current medical diagnostics market, molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in the blood--has led to this revolutionary market development. Specifically, molecular diagnostics offers the power of advanced analytical techniques to diagnose infectious diseases. Whereas before, the detection of many infectious agents was slow and expensive due to relia...Sat, 01 Dec 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/204157-breast-cancer-therapies-markets.htmlBreast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations. New market entrants must possess drug profiles and a savvy clinical development program to overcome such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. This TriMark Publications report provides comprehensive information on major and minor shapers of the breast cancer drug treatment landscape. The study includes detailed discussions on the impact of critical factors, such as genericization, patent cliffs, drug shortages, reimbursement, predictive testing and personalized medicine, to help current and contempla...Thu, 01 Nov 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75222-over-the-counter-diagnostic-products-world-markets.htmlThe purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease. This study also includes a review of home healthcare kits and devices that measure health-related conditions. Focus is on market dynamics and current market drivers of the OTC and home self-testing diagnostics market. This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market sh...Fri, 21 Sep 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75200-dna-sequencing-and-pcr-markets.htmlDNA sequencing and polymerase chain reaction (PCR) are two major technology platforms of value in life science research, drug discovery and clinical diagnostics. The markets for sequencing are extremely competitive, driven by rapid technological advancements and aggressive price wars. Next-generation sequencing presents an exciting area of growth for life science tool vendors, including those providing sequencers, ancillary instrumentation, reagents and software. This TriMark Publications report provides an in-depth analysis of key technology and market trends in the high-throughput sequencing space while analyzing the main drivers of growth in markets for PCR products and applications. The study ...Mon, 17 Sep 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/181584-clinical-laboratory-testing-volume-2-key-players-for-laboratory-testing-business-trends-and-strategies.htmlClinical laboratory testing is one of the most important sectors of medical care. Although it is generally involved in over 70% of medical diagnoses, it accounts for less than 5% of overall healthcare expenditures. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma, urine and saliva. This TriMark Publications report describes the specific segments of the clinical laboratory testing business and the strategies used by laboratory companies to develop new business opportunities. The study presents emerging business practice...Wed, 18 Jul 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75212-medical-imaging-markets.htmlThe purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. Medical imaging can be categorized into nine main modalities: X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about 108 million X-ray exams per year. MRI is second with 26 million examinations per year. PET, SPECT, CT and nuclear medicine rank third with 30 million examinations per year. Picture archiving and communication syst...Thu, 12 Jul 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/181583-clinical-laboratory-testing-volume-1-ivd-reagents-and-instruments-markets.htmlClinical laboratory in vitro diagnostic (IVD) testing for reagent and instrument sales is one of the most important sectors of medical care. By all accounts, it is a very mature, large market employing over 100,000 laboratory workers and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this TriMark Publications report is to describe the...Thu, 12 Jul 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/159597-game-changers-in-breast-cancer-therapies.htmlBreast cancer therapies are entering a new era as game-changers emerge for each of the major breast cancer patient populations. New market entrants must possess drug profiles and a savvy clinical development program to overcome such barriers to entry as a stringent regulatory environment and the incursion of cost containment within oncology. This TriMark Publications report provides comprehensive information on major and minor shapers of the breast cancer drug treatment landscape. The study includes detailed discussions on the impact of critical factors, such as genericization, patent cliffs, drug shortages, reimbursement, predictive testing and personalized medicine, to help current and contempla...Wed, 09 May 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75207-high-growth-diagnostic-testing-markets.htmlThere will be a steady increase in demand for new diagnostic testing services in the next five-year period, along with pressures to improve the quality of healthcare delivered in the clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth diagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors that influence the size and growth of market segments. The study goes on to discuss in detail trends that have deve...Mon, 30 Apr 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75199-disposable-syringe-markets.htmlThis research examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The em...Thu, 22 Mar 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75198-disposable-medical-supplies-markets.htmlThe purpose of this TriMark Publications report is to give an insight into the specific market segment called disposable medical supplies. Disposable medical supplies represent the largest segment within the global healthcare equipment and supplies sector. The disposable medical supplies include: conventional syringes with needles, prefilled syringes, disposable medical catheters, wound care products, isolation gowns, surgical drapes, facemasks, medical gloves, adult incontinence products, blood glucose test strips, lancets, lancing devices, procedure kits and trays, and disposable contact lenses. The global disposable medical supplies industry is primed to experience significant growth through th...Wed, 01 Feb 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75195-companion-diagnostics-in-personalized-medicine-and-cancer-therapy.htmlCompanion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded over the past twenty years, expanding by more than 20% annually compared to most other laboratory procedures. Research will continue to produce an increased understanding of disease processes, and diagnostics manufacturers will continue to expand and refine the technology and automation needed for ...Wed, 01 Feb 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75181-blood-glucose-testing-and-diabetes-management.htmlThere has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diab...Wed, 01 Feb 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/75229-point-of-care-diagnostic-testing-world-markets.htmlPoint of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. This TriMark Publications report describes latest developments in ...Wed, 01 Feb 2012 00:00:00 GMThttp://www.reportsnreports.com/reports/144753-hiv-aids-testing-markets.htmlThere are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions account for more than 90% of the HIV-infected population (with the highest number in Sub-Saharan Africa), the U.S. and European regions make up greater than 60% of the HIV testing market. This TriMark Publications report provides a comprehensive examination of the HIV/AIDS testing market, a specific segment of the in vitro diagnostics (IVD) market as it relates to infectious diseases. It examines the available and emerging technologies being utilized by th...Mon, 16 Jan 2012 00:00:00 GMT